Noviogendix Holding
Provider of molecular diagnostics and services to physicians, clinics, and hospitals to personalize the diagnosis and treatment of cancer.
Launch date
Market cap
-
Enterprise valuation
€8m (Public information from Sep 2015)
Irvine California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | - | |
$8.8m Valuation: $8.8m | Acquisition | ||
| Total Funding | - | ||